ONCO
Onconetix, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.02
+38.02%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$45.0K
- Revenue estimate
- $17.5K
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$1.28
- EPS estimate
- -$4.5K
- Revenue actual
- $17.1K
- Revenue estimate
- $18.3K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 2
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +25.5%
- Revenue beats (12Q)
- 1
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026